Introduction
Singleminded-2 (SIM2) is a member of the basic helixloop-helix Per-Arnt-Sim (bHLH/PAS) family of transcription factors (Kewley et al., 2004) . SIM2 is one of two mammalian orthologs of the Drosophila singleminded (sim) gene, which regulates central midline development (Crews et al., 1992) . Previous studies have demonstrated that SIM2 is differentially expressed in prostate, colon and pancreatic cancers (Deyoung et al., 2002; Aleman et al., 2005; Halvorsen et al., 2007) . We have shown that a short splice variant of SIM2, SIM2s, is expressed in human breast epithelial cells and is downregulated in primary human breast cancer samples (Kwak et al, 2007) . Reestablishment of SIM2s in highly invasive breast cancer cells significantly inhibited growth and motility, suggesting that SIM2s is a breast tumor suppressor gene. Indeed, loss of SIM2s causes aberrant mammary ductal development with features suggestive of malignant transformation including increased proliferation, changes in polarity, downregulation of E-cadherin and invasion into the surrounding stroma (Laffin et al., 2008) . Furthermore, short-hairpin RNA (shRNA)-mediated reduction of SIM2s (SIM2i) in MCF7 human breast cells promotes an epithelialmesenchymal transition (EMT) and increases tumorigenic potential. These results suggest that SIM2s is required for normal mammary ductal development and inhibition of SIM2s is permissive for acquisition of an invasive mesenchymal phenotype; however, the mechanism by which SIM2s is suppressed during breast cancer progression has not been determined.
The Ras proto-oncogene is an important effector molecule that is essential for growth-dependent induction of numerous growth factors and cytokines. Although mutations in Ras are rare in breast cancers (Khleif et al., 1999) , Ras is inappropriately activated in 50% of breast tumors and positively correlates with early neoplasia and poor prognosis (von Lintig et al., 2000) . Ras activation is also associated with ERBB2-overexpressing breast tumors, which represent 30% of breast cancer cases (Slamon et al., 1989) . Harvey-Ras (Ha-Ras)-induced tumors are characterized by activation of mitogen-activated protein kinase signaling and are cyclin D1 dependent (Yu et al., 2001; Dunn et al., 2005) . In addition, by activating oncogenic pathways, Ha-Ras overexpression, driven by the mouse mammary tumor virus promoter, induces mammary adenocarcinomas (Sinn et al., 1987; Nielsen et al., 1991) . Two Ha-Ras targets associated with breast cancer are the NOTCH signaling pathway and the CCAAT/enhance binding protein b (C/EBPb) transcription factor (Nakajima et al., 1993; Weijzen et al., 2002) . Increased NOTCH signaling has been demonstrated in a variety of human breast carcinomas (Stylianou et al., 2006) , whereas C/EBPb has been identified as an important mediator of Ras-induced tumorigenesis in a mouse skin carcinogenesis model known to cause Ha-Ras mutations (Zhu et al., 2002; Shuman et al., 2004; Shim et al., 2005) . In the studies presented here, we show that Ha-Rasmediated transformation of MCF10A normal breast epithelial cells leads to a decrease in SIM2s expression resulting from C/EBPb induction and NOTCH signaling.
Results and discussion
Ha-Ras transformation of MCF10A decreases SIM2s gene expression To define the mechanisms by which SIM2s is silenced in breast cancer, normal immortalized breast MCF10A cells were stably transduced with control vector or Ha-Ras expression constructs. Ha-Ras-MCF10A cells displayed hallmarks of transformation and EMT including a significant increase in invasion, anchorageindependent growth (data not shown), focus formation ( Figure 1a ) and downregulation of E-cadherin protein levels ( Figure 1c ) as compared to control cells. Evaluation of SIM2s expression in Ha-Ras-MCF10A cells, using real-time PCR and western blot analysis, showed a significant decrease in SIM2s mRNA ( Figure 1a ) and protein levels (Figure 1b) , respectively. These results suggest that SIM2s is downregulated during Ha-Rasdependent transformation and pathways downstream of Ha-Ras suppress SIM2s gene expression.
Reduction of SIM2s in MCF10A cells by shRNA induces an invasive EMT-like phenotype To determine if downregulation of SIM2s contributes to Ha-Ras-mediated transformation of MCF10A cells, we stably silenced SIM2s in MCF10A cells using a previously confirmed SIM2s-specific lentivirus shRNA construct (Laffin et al., 2008) (Figures 2a and b) . When grown in three-dimensional cultures, control MCF10A cells formed regular, spherical acini, whereas a majority of SIM2i MCF10A acini were misshapen with cells budding into the surrounding matrix (Figure 2c ). Loss of SIM2s also correlated with significantly increased in vitro invasive potential (Figure 2d ). Furthermore, western blots showed that SIM2i-MCF10A cells had decreased E-cadherin and increased vimentin expression ( Figure 2e ). Together, these results show that reduction of SIM2s in MCF10A cells to levels observed in . Differential contrast imaging of cells following 2 days of selection in medium containing 1 mg/ml puromycin, cells, showed that Ha-Ras-transduced cells lost their normal ovoid shape and displayed abnormal cellular organization. Ha-Ras construct was provided by Brian and Alana Welm and subcloned into EcoRI sites in pLPCX (Clontech). (b, c) SIM2s and E-cadherin expression is decreased in Ha-Ras-overexpressing MCF10A cells. Total RNA and protein were isolated from control (pLPCX) and Ha-Ras-overexpressing cells (HRAS) and analysed for SIM2s expression by quantitative realtime RT-PCR and western analysis (Chemicon) as previously described (Laffin et al., 2008) . The results show that SIM2s and E-cadherin expression are significantly reduced in Ha-Ras-transduced MCF10A cells in comparison to control cells (mean ± s.e. for three replicates; *P ¼ 0.0002).
Ha-Ras-transformed MCF10A cells induces an invasive EMT-like phenotype.
Activation of NOTCH in Ha-Ras-MCF10A cells represses SIM2s through a CBF1-independent mechanism
Increased NOTCH signaling has been demonstrated in a variety of human breast carcinomas (Stylianou et al., 2006) . Studies have shown that Ha-Ras activates NOTCH, which is required to maintain the transformed phenotype in human cells (Weijzen et al., 2002) . Activation of NOTCH signaling is an important mediator of Ras-induced tumorigenesis in the mouse mammary gland and is also implicated in stem cell maintenance (Weijzen et al., 2002; Kiaris et al., 2004; Sansone et al., 2007) . Indeed, in Ha-Ras-MCF10A cells we observed a significant increase in the expression of known NOTCH target genes HES1, HEY1 and HEY2 by real-time PCR (Figures 3a-c) and detection of the NOTCH intracellular domain (NICD) by western blot analysis (Figure 3d ), indicating that the NOTCH pathway is active in these cells. Furthermore, treatment with the g-secretase inhibitor, DAPT (N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester), significantly blocked NOTCH-induced expression of HES1 and suppression of SIM2s gene expression (Figures 3e and f) , implying that Ha-Ras-activated NOTCH signaling targets SIM2s.
Previous studies have shown that the canonical NOTCH signaling pathway acts through C-repeat binding factor 1 (CBF1) to govern normal developmental processes (Bray, 2006) . In addition, CBF1-independent mechanisms of NOTCH signaling that contribute to cell fate determination have also been identified (Martinez Arias et al., 2002) . To evaluate the function of NOTCH signaling in regulation of SIM2s, a SIM2 promoter-luciferase reporter construct was cotransfected in the presence or absence of NICD or CBF1 expression vectors. NICD significantly repressed SIM2 promoter activity (Po0.0004); however, CBF1 had no effect on SIM2 promoter activity, suggesting a CBF1-independent mechanism of SIM2s repression by the NOTCH signaling pathway (Figure 3g ). NICD function was confirmed using an HES1 promotercontrolled reporter. As expected, reporter activity was increased in cells cotransfected with either NICD or NICD plus CBF1, but not in CBF1 cells alone (Jarriault et al., 1995;  Figure 3h ). To determine whether SIM2 was a direct target of NICD, chromatin immunoprecipitation (ChIP) assays were employed to evaluate the region near the transcriptional start site of the SIM2 promoter (Figure 3i) . The results show increased binding of NICD to the endogenous SIM2 promoter in Ha-Ras-overexpressing cells, suggesting that activation of NOTCH and release of the NICD by Ha-Ras contributes to inhibition of SIM2s expression.
C/EBPb-dependent regulation of SIM2s in vitro and in vivo C/EBPb is a member of the basic leucine zipper family of transcription factors, which has an important MCF10A cells transduced with a confirmed SIM2-specific construct (SIM2s-sequence 3116; SIM2i) showed a significant reduction in SIM2s mRNA and protein as compared to a nonspecific control shRNA retroviral construct (Scr) (Laffin et al., 2008) . (c) Low-and highpower differential interference contrast images of MCF10A acini grown on matrigel demonstrate that acinar morphogenesis is disrupted in SIM2i MCF10A cells as compared to Scr control. (d) SIM2i MCF10A cells display an increased ability to invade through a matrigel matrix using transwell invasion assays (Kwak et al., 2007) . (e) Loss of SIM2s induces a partial EMT. Western blot analysis of Scr and SIM2i cells found that E-cadherin expression is reduced and vimentin expression is increased in SIM2i MCF10A cells as compared to Scr controls and is consistent with an EMT-like phenotype (Laffin et al., 2008) . Data are represented as mean±s.e.m., asterisk (*) indicates Po0.05; Bar ¼ 100 mM. function in mammary development and has recently been shown to be a critical mediator of Ras-induced tumorigenesis (Seagroves et al., 1998; Zhu et al., 2002; Grimm and Rosen, 2003) . The C/EBPb gene encodes a single 1.4 kb mRNA that, through alternative translation start sites, leads to production of three isoforms: LAP1, LAP2 and the dominant negative isoform, LIP. Both LAP isoforms contain the DNA binding and dimerization domains, whereas LIP is missing the transactivation domain and antagonizes LAP-mediated gene transcription by competing for LAP binding sites or by forming LIP/LAP heterodimers (Descombes and Schibler, 1991) . The ratio of LAP to LIP has been proposed to have an important function in breast cancer (Zahnow, 2002; Grimm and Rosen, 2003) . A low LIP/ LAP ratio, indicating an increase in LIP expression, is associated with higher histological grading (Zahnow et al., 1997; Milde-Langosch et al., 2003) and has recently been shown to point toward a loss of transforming growth factor-b-cytostatic responses (Gomis et al., 2006) . Indeed, overexpression of LIP in mouse mammary glands causes an increase in prolifera-tion resulting in hyperplasias and invasive carcinoma (Zahnow et al., 2001) . Although C/EBPb is associated with breast cancer, its specific function in tumorigenesis is not well understood.
To determine the effect of Ha-Ras transformation on C/EBPb, we used western blot analysis to evaluate levels of LAP1, LAP2 and LIP in Ha-Ras-MCF10A cells. These data revealed similar levels of LAP1 and LAP2; however, there was a significant increase in the truncated dominant negative isoform (LIP) in the HaRas-MCF10A cells (Figure 4a ). This is consistent with recent studies showing Ha-Ras-dependent induction of EGFR, which induces LIP (Martinez-Lacaci et al., 2000; Baldwin et al., 2004) . To confirm if the increase in LIP alone alters SIM2s, MCF10A cells were stably transduced with control (pBABE), LAP1, LAP2 or LIP vectors. Western blot analysis revealed that LAP1 and LAP2 did not affect SIM2s levels, whereas overexpression of LIP leads to a reduction in SIM2s protein (Figure 4b ).
C/ebpb À/À mice are viable, but display immune system defects, abnormal brown adipose tissue function, skin irregularities and female infertility (Grimm and Rosen, 2003) . In addition, mammary glands from C/ebpb À/À mice have impaired ductal outgrowth and differentiation due to a disruption in cell fate determination (Seagroves et al., 1998) . We have previously shown that SIM2s is expressed in luminal mammary epithelial cells and is required for proper ductal morphogenesis (Laffin et al., 2008) . Using real-time PCR, we found that SIM2s is significantly increased in C/ebpb À/À mammary glands when compared to wild-type mice (Figure 4c ). The increase in SIM2s was confirmed at the protein level by immunohistochemistry and was found uniformly in the luminal epithelial cells of C/ebpb null glands, compared to the more punctate expression pattern seen in wild-type glands (Figure 4d ). To define further the relationship between C/ebpb and SIM2s, we used an immortalized cell line established from mammary glands of C/ebpb null virgin females. When compared to control cells, SIM2s expression was significantly increased in this in vitro model, consistent with the in vivo data. Furthermore, reestablishing each of the three C/ebpb isoforms by lentiviral transduction (Figure 4f ) led to a reduction in SIM2s expression (Figure 4g) . Together, these results show that SIM2s is differentially regulated by C/EBPb under both transforming and normal developmental conditions.
In summary, we have identified a pathway connecting Ha-Ras activation to SIM2s silencing through NOTCH and C/EBPb. Ha-Ras has been shown to promote cleavage of NOTCH, releasing the active NICD (Weijzen et al., 2002) , and to increase the LIP/LAP ratio (Nakajima et al., 1993) . In addition, we also found that activation of NOTCH and C/EBPb by Ha-Ras independently regulate SIM2s expression. We observed no changes in the LIP/LAP isoforms in Ha-Ras-MCF10A cells following treatment with a g-secretase inhibitor (Supplementary Figure 1a) , which we had previously shown to block RAS-mediated activation of HES1 and partially alleviated SIM2s suppression (Figures 3e and f) , nor upregulation of NOTCH or NOTCH target genes HES1 and HEY1 in LIPtransduced MCF10A cells (Supplementary Figure 1b  and c) . We do not suggest that these are the only mediators of SIM2s repression in breast cancer cells, because Ras signaling affects many other pathways including phosphatidylinositol 3-kinase. Also, it will be important to evaluate SIM2s expression in other epigenetic and oncogene-driven models of breast cancer, such as MYC and WNT. Because NOTCH and C/EBPb are differentially expressed in differing tumor types, these results may also explain the oncogenic function SIM2s has in pancreatic and prostate cancers (Sundaram, 2005; Gomis et al., 2006) . It is of interest that two proteins involved in cell fate determination independently regulate SIM2s (Liu et al., 2005) , suggesting that SIM2s has a function in mammary gland cell fate, possibly directing cells to differentiate. Future studies using gain-and loss-of-function mouse mammary gland models will elucidate the function of SIM2s in this process. We believe that downregulation of SIM2s expression is a requirement for breast cancer progres- Effect of NICD and C-repeat binding factor 1 (CBF1) on HES1 and SIM2 promoter activity. Promoter reporter assays using either SIM2 or HES1 promoter constructs were (diagrammed above) cotransfected with vector control, NICD, CBF1 or both in HEK293T cells as previously described (Metz et al., 2006) . The results show that HES1 promoter activity was significantly increased by NICD and NICD/CBF1 cotransfection compared to vector control, whereas SIM2 luciferase activity was suppressed by the NICD, independent of CBF1 (*Pp0.001). Data are expressed as the mean ± s.e. for three wells per condition. The SIM2 promoter was amplified in two pieces with primers 5-ATCTGGGTAATCCCTTT CAAGCC-3 and 5-CCTGAGCTCCGAGCAACC-3, and 5-GTGGACAGCGGAGGTGCT-3 and 5-CCAAACCAAACCA GAATGC-3. Each piece was cloned onto pCR2.1 TOPO. The former fragment was subcloned onto pGL2 Basic into KpnI and XhoI restriction sites. The latter fragment was then subcloned into SacI and XhoI restriction sites to obtain the full-length SIM2 promoter on pGL2 Basic. (i) Binding of NOTCH to the SIM2 promoter. Chromatin immunoprecipitation (ChIP) analysis of the SIM2 promoter (Laffin et al., 2008) (Laffin et al., 2008) . (e) SIM2s expression in a C/ebpb À/À mouse mammary epithelial cell line. Similar to the C/ebpb À/À mammary glands, SIM2s levels are increased in mouse mammary epithelial cells derived from C/ebpb À/À mammary glands (Lamb et al., 2003) by real-time RT-PCR as compared to normal HC11 cells (*Pp0.001). (f, g) Reestablishment of mouse C/ebpb isoforms in the C/ebpb À/À cells as determined by western blot analysis correlates with a decrease in SIM2s mRNA levels (*Pp0.001). Data are expressed as the mean ± s.e. for three plates per condition. sion, and that elucidating pathways involved in SIM2s silencing will aid in the development of targeted therapies for treatment of this disease.
